This article is more than 5 years old. Information may no longer be current.
Cleveland Clinic fills two leadership posts
Click Here to Manage Email Alerts
Cleveland Clinic recently appointed two physicians to leadership positions.
Navneet Majhail, MD, MS, is the new director of the bone marrow transplant program at Cleveland Clinic’s Taussig Cancer Institute. Majhail is board certified in internal medicine and hematology, and he specializes in the care of adult patients receiving blood and marrow transplantation.
Before joining Cleveland Clinic, he was medical director of health services research at the National Marrow Donor Program and an adjunct associate professor of medicine with the University of Minnesota. His research focuses on health services and health policy issues in blood and marrow transplantation and quality of life and late effects in transplant survivors.
Navneet Majhail
Majhail also serves as assistant scientific director with the Center for International Blood and Marrow Transplant Research, an international clinical outcomes registry of patients receiving blood and marrow transplantation.
Jame Abraham, MD, FACP, is the new director of the breast cancer program at Cleveland Clinic’s Taussig Cancer Institute. Before joining Cleveland Clinic, Abraham was the Bonnie Wells Wilson distinguished professor and eminent scholar in breast cancer research and section chief of hematology/oncology at West Virginia University.
Jame Abraham
He is a member the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer committee, breast cancer working committee and advisory board of the division of industry trials. Abraham also is the national study chair for the NSABP FB-9 clinical trial studying the role of eribulin in early-stage breast cancer. His research focus has been developing novel therapies, risk stratification and novel diagnostic approaches for breast cancer.